Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The European Commission has been called upon to investigate into a so-called 'postcode lottery' in the UK where one local health authority can deny funding for life-prolonging drugs, despite funding being available elsewhere.
Subscribe to our email newsletter
MEP Chris Heaton-Harris has asked the Commission to look into UK drug distribution on the grounds that it breaks European anti-discrimination laws.
Mr Heaton-Harris is defending a patient who has been denied cancer drug Sutent by his local primary care trust, and is having to pay for the treatment himself.
The patient, Mr Jones from Rugby, Warwickshire, is currently paying GBP3,400 a month for his daily dosage of Pfizer's Sutent for the treatment of abdominal cancer.
Warwickshire PCT has denied that its decision to deny the drug was based on cost, although the drug is funded by other PCTs in the UK.